it is also used for other indications such as the treatment of premenopausal breast cancer uterine fibroids and early puberty in assisted reproduction for female infertility and as a part of transgender hormone therapy in addition buserelin is used in veterinary medicine the medication is typically used as a nasal spray three times per day but is also available for use as a solution or implant for injection into fat side effects of buserelin are related to sex hormone deprivation and include symptoms of low testosterone levels and low estrogen levels such as hot flashes sexual dysfunction vaginal atrophy and osteoporosis buserelin is a gonadotropin releasing hormone agonist gnrh agonist and works by preventing the production of sex hormones by the gonads it can lower sex hormone levels by about 95 in both sexes buserelin is a peptide and an analogue of buserelin was first patented in 1974 and approved for medical use in 1985 it is not available in the united states but is marketed widely elsewhere in the world including in the united kingdom canada and many other countries the medication is one of only two medically used gnrh analogues that are available as nasal sprays the other